Selegiline Transdermal System in the Prevention of Relapse of Major Depressive Disorder: A 52-Week, Double-blind, Placebo-Substitution, Parallel-Group Clinical Trial
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: Jay D. Amsterdam, J. Alexander Bodkin
Institutions: University of Pennsylvania, Harvard University, McLean Hospital
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2054339311
